PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Mar-2022 Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie Novo Holdings
02-Mar-2022 V-Bio Ventures’ Portfolio Company Syndesi Therapeutics Acquired by AbbVie to Strengthen its Neuroscience Portfolio V-Bio Ventures
02-Mar-2022 StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort Tiziana Life Sciences Ltd
02-Mar-2022 BC Platforms Opens Singapore R&D Center and Signs New Data Partnership to Drive Precision Medicine in Asia Pacific Region BC Platforms
02-Mar-2022 CHAPPER healthcare to distribute pioneering asthma management tool in UK & Ireland CHAPPER healthcare
02-Mar-2022 International Society for Cell & Gene Therapy establishes working group to tackle regulatory and ethical issues with Expanded Access International Society for Cell & Gene Therapy
02-Mar-2022 Actigen Initiates a Development Programme in Rare Disease MPS II Actigen
02-Mar-2022 Surgical Drapes and Gowns Market Is Booming Worldwide 2022-2029 | Top Key Players – 3M, J&J, Cardinal Health The Wire Times
02-Mar-2022 Hospital Laboratory Information Management Systems Market to Discern Magnified Growth during 2022-2029 | CliniSys, Abbott, Agilent The Wire Times
02-Mar-2022 Giardiasis Treatment Market 2022-2029: Increasing Demand Of Substitutes & Rising Number Of Market Players – Roche, Teva, Sun Pharma The Wire Times
02-Mar-2022 Analyses from NAVIGATOR and PATHWAY trials presented at the 2022 AAAAI Annual Meeting AstraZeneca
02-Mar-2022 Flow Cytometry Market Projected to Exhibit a Double-Digit CAGR between 2022 and 2029 | BD, Sony Biotechnology, Merck, Agilent The Wire Times
02-Mar-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Mar-2022 Glucophage® is the First Oral Diabetes Treatment Approved in Europe for use during Pregnancy Merck
02-Mar-2022 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial Bavarian Nordic
02-Mar-2022 Santhera Signs Gene Therapy Agreement with SEAL Therapeutics Santhera Pharmaceuticals
02-Mar-2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients Vifor Pharma Group
02-Mar-2022 Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis Sanofi
02-Mar-2022 Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria Sanofi
02-Mar-2022 FDA Accepts for Review Pfizer’s Supplemental Application for ABRILADA™ (adalimumab-afzb) Interchangeability Pfizer Inc.